NFE2L2 and type 1 diabetes mellitus: Although evidence exists that activation of the Keap1/Nrf2 signaling pathway exerts favorable effects on T1DM, systematic in vivo and in vitro studies involving the intervention of the Keap1/Nrf2 signaling pathway on the onset of T1DM have not yet been explored.